ON DEMAND: ESMO 2021 – ‘Game-Changers’ in melanoma, lung, gynae, brain and head&neck cancer

7 Oct 2021

This week an expert panel presented game-changing data from the ESMO 2021 Congress in melanoma, lung, gynae, brain head&neck cancer, and discussed the impacts for Australian practice.

If you didn’t catch the webinar, you can watch on demand here:

Hosted by Dr Steven Kao

Medical Oncology Staff Specialist, Chris O’Brien Lifehouse; Research Fellow, Asbestos Diseases Research Institute and Senior Lecturer, University of Sydney.


Melanoma: Professor Georgina Long AO. Co-Medical Director of Melanoma Institute Australia (MIA); Chair, Melanoma Medical Oncology and Translational Research, MIA and Royal North Shore Hospital, The University of Sydney.

Gynae: Professor Michael Friedlander AM. Medical Oncologist, Royal Hospital for Women and The Prince of Wales Hospital, Sydney; Inaugural Chair and Co-Founder, ANZGOG; Conjoint Professor of Medicine, The University of New South Wales.

Brain, head & neck: Dr. Elizabeth Ahern. Medical Oncologist, Monash Health; Postdoctoral Research Fellow, Monash University; Visiting Scientist, Queensland Institute of Medical Research (Berghofer).

Lung: Professor Nick Pavlakis. Senior Staff Specialist, Department of Medical Oncology, Royal North Shore Hospital, Sydney. Board Chair, TOGA; President, Australasian Lung Cancer Trials Group; Past President, COSA.


This event was created independently by the limbic in collaboration with the host and presenters. All studies were selected by the presenters, and all views expressed were those of the host and presenters only. Thank you to our sponsors for providing the non-restrictive educational sponsorship that made this program possible.  

Already a member?

Login to keep reading.

Email me a login link